Vivanza Biosciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	1,100	74.23	278.35	178.07	104	98.88
Other Revenue	1.36	0.48	0.54	3.47	7.99	0.51
Revenue	1,102	74.72	278.89	181.54	111.99	99.4
Revenue Growth (YoY)	870.71%	-73.21%	53.62%	62.10%	12.67%	3.31%
Cost of Revenue	1,091	68.21	259.51	165.06	96.54	91.53
Gross Profit	10.86	6.51	19.39	16.48	15.46	7.87
Selling, General & Admin	6	5.98	4.51	3.51	3.24	3.47
Other Operating Expenses	3.15	3.44	3.67	1.6	3.65	1.51
Operating Expenses	9.29	9.56	8.3	5.13	6.96	5.08
Operating Income	1.58	-3.05	11.08	11.35	8.5	2.78
Interest Expense	-2.93	-3.51	-4.13	-4.19	-4.06	-4.68
Interest & Investment Income	-	-	-	-	-	4.23
Currency Exchange Gain (Loss)	-0.09	-0.09	-	-	-1.1	-1.1
Other Non Operating Income (Expenses)	-0	-0	-	-	-0	-
EBT Excluding Unusual Items	-1.45	-6.66	6.95	7.16	3.33	1.23
Pretax Income	-1.45	-6.66	6.95	7.16	3.33	1.23
Income Tax Expense	0.08	0.08	1.48	1.18	0	0.48
Net Income	-1.53	-6.74	5.47	5.98	3.33	0.75
Net Income to Common	-1.53	-6.74	5.47	5.98	3.33	0.75
Net Income Growth	-	-	-8.52%	79.67%	342.02%	-
Shares Outstanding (Basic)	40	40	39	40	40	40
Shares Outstanding (Diluted)	40	40	39	40	40	40
Shares Change (YoY)	-1.23%	2.32%	-2.27%	-	-	-
EPS (Basic)	-0.04	-0.17	0.14	0.15	0.08	0.02
EPS (Diluted)	-0.04	-0.17	0.14	0.15	0.08	0.02
EPS Growth	-	-	-6.40%	80.21%	340.72%	-
Free Cash Flow	-	-25.07	20.06	-9.46	24.67	-27.86
Free Cash Flow Per Share	-	-0.63	0.51	-0.24	0.62	-0.70
Gross Margin	0.99%	8.71%	6.95%	9.08%	13.80%	7.91%
Operating Margin	0.14%	-4.08%	3.97%	6.25%	7.58%	2.80%
Profit Margin	-0.14%	-9.02%	1.96%	3.30%	2.97%	0.76%
Free Cash Flow Margin	-	-33.55%	7.19%	-5.21%	22.03%	-28.02%
EBITDA	1.73	-2.91	11.2	11.38	8.57	2.88
EBITDA Margin	0.16%	-3.90%	4.02%	6.27%	7.65%	2.90%
D&A For EBITDA	0.15	0.14	0.12	0.03	0.07	0.1
EBIT	1.58	-3.05	11.08	11.35	8.5	2.78
EBIT Margin	0.14%	-4.08%	3.97%	6.25%	7.58%	2.80%
Effective Tax Rate	-	-	21.27%	16.48%	0.12%	38.99%
Revenue as Reported	1,102	74.85	278.89	182.82	112.29	103.94
Advertising Expenses	-	0.05	0.04	0.08	0.03	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.